» Articles » PMID: 31993713

Associations of Dicarbonyl Stress with Complement Activation: the CODAM Study

Overview
Journal Diabetologia
Specialty Endocrinology
Date 2020 Jan 30
PMID 31993713
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Aims/hypothesis: Reactive α-dicarbonyl compounds are major precursors of AGEs and may lead to glycation of circulating and/or cell-associated complement regulators. Glycation of complement regulatory proteins can influence their capacity to inhibit complement activation. We investigated, in a human cohort, whether greater dicarbonyl stress was associated with more complement activation.

Methods: Circulating concentrations of dicarbonyl stress markers, i.e. α-dicarbonyls (methylglyoxal [MGO], glyoxal [GO] and 3-deoxyglucosone [3-DG]), and free AGEs (N-(carboxymethyl)lysine [CML], N-(carboxyethyl)lysine [CEL] and N-(5-hydro-5-methyl-4-imidazolon-2-yl)-ornithine [MG-H1]), and protein-bound AGEs (CML, CEL, pentosidine), as well as the complement activation products C3a and soluble C5b-9 (sC5b-9), were measured in 530 participants (59.5 ± 7.0 years [mean ± SD], 61% men) of the Cohort on Diabetes and Atherosclerosis Maastricht (CODAM) study. Multiple linear regression analyses were used to investigate the associations between dicarbonyl stress (standardised) and complement activation (standardised) with adjustment of potential confounders, including age, sex, lifestyle, use of medication and markers of obesity. In addition, the associations of two potentially functional polymorphisms (rs1049346, rs2736654) in the gene encoding glyoxalase 1 (GLO1), the rate-limiting detoxifying enzyme for MGO, with C3a and sC5b-9 (all standardized) were evaluated.

Results: After adjustment for potential confounders, plasma concentration of the dicarbonyl GO was inversely associated with sC5b-9 (β -0.12 [95% CI -0.21, -0.02]) and the protein-bound AGE CEL was inversely associated with C3a (-0.17 [-0.25, -0.08]). In contrast, the protein-bound AGE pentosidine was positively associated with sC5b-9 (0.15 [0.05, 0.24]). No associations were observed for other α-dicarbonyls and other free or protein-bound AGEs with C3a or sC5b-9. Individuals with the AG and AA genotype of rs1049346 had, on average, 0.32 and 0.40 SD lower plasma concentrations of sC5b-9 than those with the GG genotype, while concentrations of C3a did not differ significantly between rs1049346 genotypes. GLO1 rs2736654 was not associated with either C3a or sC5b-9.

Conclusions/interpretation: Plasma concentrations of dicarbonyl stress markers showed distinct associations with complement activation products: some of them were inversely associated with either C3a or sC5b-9, while protein-bound pentosidine was consistently and positively associated with sC5b-9. This suggests different biological relationships of individual dicarbonyl stress markers with complement activation.

Citing Articles

An interferon-related signature characterizes the whole blood transcriptome profile of insulin-resistant individuals-the CODAM study.

Kalafati M, Kutmon M, Evelo C, van der Kallen C, Schalkwijk C, Stehouwer C Genes Nutr. 2021; 16(1):22.

PMID: 34886800 PMC: 8903498. DOI: 10.1186/s12263-021-00702-7.


Investigation of the Initial Host Response of Naïve Atlantic Salmon () Inoculated with .

McCormack M, Dillon E, OConnor I, MacCarthy E Microorganisms. 2021; 9(4).

PMID: 33918228 PMC: 8066739. DOI: 10.3390/microorganisms9040746.


Polymorphisms in Glyoxalase I Gene Are Not Associated with Glyoxalase I Expression in Whole Blood or Markers of Methylglyoxal Stress: The CODAM Study.

Maasen K, Hanssen N, van der Kallen C, Stehouwer C, van Greevenbroek M, Schalkwijk C Antioxidants (Basel). 2021; 10(2).

PMID: 33540757 PMC: 7913097. DOI: 10.3390/antiox10020219.

References
1.
Gaens K, Goossens G, Niessen P, Van Greevenbroek M, van der Kallen C, Niessen H . Nε-(carboxymethyl)lysine-receptor for advanced glycation end product axis is a key modulator of obesity-induced dysregulation of adipokine expression and insulin resistance. Arterioscler Thromb Vasc Biol. 2014; 34(6):1199-208. DOI: 10.1161/ATVBAHA.113.302281. View

2.
Fluckiger R, Cocuzzi E, Nagaraj R, Shoham M, Kern T, Medof M . DAF in diabetic patients is subject to glycation/inactivation at its active site residues. Mol Immunol. 2017; 93:246-252. PMC: 5884443. DOI: 10.1016/j.molimm.2017.06.036. View

3.
Engelen L, Ferreira I, Brouwers O, Henry R, Dekker J, Nijpels G . Polymorphisms in glyoxalase 1 gene are not associated with vascular complications: the Hoorn and CoDAM studies. J Hypertens. 2009; 27(7):1399-403. DOI: 10.1097/HJH.0b013e32832af6ba. View

4.
Hair P, Echague C, Rohn R, Krishna N, Nyalwidhe J, Cunnion K . Hyperglycemic conditions inhibit C3-mediated immunologic control of Staphylococcus aureus. J Transl Med. 2012; 10:35. PMC: 3328285. DOI: 10.1186/1479-5876-10-35. View

5.
Kislinger T, Fu C, Huber B, Qu W, Taguchi A, Du Yan S . N(epsilon)-(carboxymethyl)lysine adducts of proteins are ligands for receptor for advanced glycation end products that activate cell signaling pathways and modulate gene expression. J Biol Chem. 1999; 274(44):31740-9. DOI: 10.1074/jbc.274.44.31740. View